LENSAR, Inc. (LNSR) NASDAQ
5.74
+0.07(+1.23%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.74
+0.07(+1.23%)
Currency In USD
| Previous Close | 5.67 |
| Open | 5.83 |
| Day High | 5.83 |
| Day Low | 5.61 |
| 52-Week High | 13.67 |
| 52-Week Low | 5.06 |
| Volume | 44,383 |
| Average Volume | 118,671 |
| Market Cap | 69.48M |
| PE | -10.44 |
| EPS | -0.55 |
| Moving Average 50 Days | 5.7 |
| Moving Average 200 Days | 10.2 |
| Change | 0.07 |
LENSAR® Provides Update on Pending Acquisition by Alcon
GlobeNewswire Inc.
Feb 25, 2026 10:00 PM GMT
ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an update on th
Alcon Agrees to Acquire LENSAR, Inc.
GlobeNewswire Inc.
Mar 24, 2025 12:00 PM GMT
Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolioNext generation technology will be expanded globally, improving the efficiency of cataract surgery GENEVA and ORLANDO, Fla., March 24,
LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025
GlobeNewswire Inc.
Feb 19, 2025 5:00 PM GMT
ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Compa